Pharmaceutical/Biotech Case Studies

New Intraveneous Drug Therapies Possible Due to Microfluidizer Processing.

Excerpt: "Thanks in part to the Microfluidizer® Processor, doctors can administer new kinds of drugs to patients - drugs that previously could not be absorbed through the digestive tract and could not be administered by injection without risking the blockage of blood vessels. Earlier work with the Microfluidizer® Processor has already allowed patients to receive intravenous dosages of insoluble fatty oils, giving them more energy during convalescence and prompting faster recoveries." (click to download PDF) 36K

Genetic Researchers Score a Bargain: Free Delivery of DNA.

Excerpt: "A researcher at the University of Pittsburgh has found a way to deliver virtually any amount of DNA for treatment of any disease, without using viruses as a delivery vehicle."

Subject: Avoiding the expense of virus-based DNA delivery by using cheaply produced, less complicated Liposomes as a delivery medium. (click to download PDF) 48K

Helping Cancer Patients Take Their Medicine.

Excerpt: "The purpose of the study is to determine if a new method for delivering a cytotoxic drug is safe and effective — one that allows such drugs to be administered intravenously rather than orally, with far fewer side effects and much greater patient comfort. The breakthrough behind this new approach is the mixing technology embodied in the Microfluidizer® Processor."
(click to download PDF) 36K

Microfluidizer Processor helps increase the odds of discovery at Tularik.

Subject: " 'The harvest and yield of the protein, needed for the assay, depends in a large part on how efficiently we crack the E.coli host cells,' says Heilek-Snyder.[Gabrielle Heilek-Snyder PhD of Tularik Inc. ed.] 'But it's not just getting the protein out that's important, the protein must still be active. The advantage of the Microfluidizer® Processor is that it allows us to break the E. coli fast, with minimal impact on the cell's internal compartments."
(click to download PDF) 44K

Race Is On To Discover Vaccine To Save Salmon

Subject: " 'Originally we worked with a French press and Gaulin homogenizer, but they posed contamination and equipment cleaning problems. After a demonstration here at our lab, the Microfluidizer processor's performance and sterilization features convinced us to get one immediately."
(click to download PDF) 32Ks